Cardioplegia Round Table Discussion: Mee (EP Video)
Ron Shelton discusses the merits of "Mee" cardioplegia (3:31 minutes).
Cardioplegia Round Table Discussion: Crystalloid (EP Video)
Brandon Shade discusses his experience with using crystalloid cardioplegia (1:14 minutes).
Transplant Ethics (EP Video)
Dr. Joseph W. Rossano discusses the history and ethics of heart transplantation (56:44 minutes).
Sanguinous vs. Asanguinous Priming in Pediatric Perfusion (EP Video)
Lorrie Graf discusses the dilemma of sanguinous vs. sanguinous priming for pediatric patients (15:30 minutes).
VADs: Then and Now (EP Video)
Vince Olshove discusses the evolution of ventricular assist devices (31:11 minutes).
2013 Pediatric Perfusion Survey Results (EP Video)
Jorge Molina discusses the results of the 2013 pediatric perfusion survey (28:38 minutes).
MUF 102: Arterio-Arterial MUF (EP Video)
Jorge Molina discusses advanced concepts of arterio-arterial modified ultrafiltration (19:13 minutes).
Cardioplegia Round Table Discussion: Custodial (EP Video)
Jorge Molina discusses his vast experience with Cursidial cardioplegia (4:24 minutes).
Have Recent Advances in Pediatric CPB Made Modified Ultrafiltration Obsolete? (EP Video)
Craig McRobb ponders whether new advances in pediatric CPB have rendered modified ultrafiltration obsolete (26:46 minutes).
Cardioplegia Round Table Discussion: Del Nido (EP Video)
Gregory Matte discusses his experience with Del Nido cardioplegia (4:57 minutes).
Aortic Valve Insufficiency in the Teenager and Young Adult: The Role of Prosthetic Valve Replacement
This article discusses the current state of knowledge regarding mechanical and bioprosthetic valve prostheses and their specific advantages relative to valve repair or a Ross procedure.
Bridging Anti Platelet Therapy in Patients Requiring Cardiac and Non-Cardiac Surgery: From Bench to Bedside
This article explores the theoretical background and rationale for bridging patients on antiplatelet drugs to their surgical procedure, and provides insights on how patient and procedural characteristics translate into different considerations for the use of antithrombotic agents in the surgical setting.